Navigation Links
Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
Date:2/19/2008

ASHBURN, Va., Feb. 19 /PRNewswire/ -- Innocoll, Inc., a privately-held specialty pharmaceutical company, announced that the second of two phase 3 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the prevention of surgical site infections, has commenced dosing.

GENTAMICIN SURGICAL IMPLANT is a fully biodegradable, leave-behind surgical implant impregnated with the broad spectrum aminoglycoside antibiotic, gentamicin. It is designed to provide a high concentration of gentamicin (which has a concentration-dependent mechanism of action) directly to the target tissue for localized action, while maintaining low systemic levels well below the toxicity threshold. The product was developed using Innocoll's proprietary collagen-based drug delivery technology, CollaRx, and (outside of the US) is indicated as an adjunct to systemic antibiotic therapy for the treatment of localized, deep tissue infections and the prevention of surgical site infections in both hard and soft tissues. GENTAMICIN SURGICAL IMPLANT is already approved in 49 countries spanning Europe, Latin America, Middle East, Africa and Asia and there are more than 60 prospective clinical trials and published case reports totaling over 7,500 patients documenting its safety and efficacy over a broad range of orthopedic, colorectal, cardiothoracic, vascular, and neurosurgical procedures.

According to advice from FDA received at both pre-IND and post-IND meetings held in 2007, Innocoll will conduct two multi-centered phase 3 clinical trials in the US to support the planned New Drug Application (NDA). The first trial in cardiac surgery patients at higher risk of surgical site infection commenced in December 2007. The second trial, which has now enrolled its first patient, is in general surgery patients undergoing open colorectal surgery. Innocoll has appointed Duke University's Duke Clinical Research Instit
'/>"/>

SOURCE Innocoll, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
2. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
3. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
4. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
5. Advanced Life Sciences Announces Successful Thorough QT Study of Cethromycin
6. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
7. TorreyPines Therapeutics Announces Strategic Plan with Focus on Clinical Development Activities to Maximize Value of Versatile Lead Compounds
8. Raven Announces Completion of Enrollment in the Phase 1/2a Clinical Trial of RAV12 Therapeutic Antibody for the Treatment of Adenocarcinomas
9. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
10. Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future
11. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... --Aethlon Medical, Inc. (OTCQB:AEMD), the pioneer in developing targeted ... announced that James A. Joyce , Aethlon Medical ... the 27th Annual ROTH Conference on March 10, 2015 ... California . To learn more about the ROTH ... live webcast of the presentation will be available on ...
(Date:3/4/2015)... 2015  Students from Indiana University School of Medicine ... are discovered. Through a partnership with Lilly ... IU School of Medicine are learning about drug development ... different and important roles in bringing new and innovative ... educator, scientific investigator, and health system administrator, I recognize ...
(Date:3/4/2015)... LAKE CITY , March 4, 2015  ECR ... VAR ) is showcasing a full spectrum of ... improve image quality, reduce costs, and enable greater patient ... cone-beam CT imaging systems.  These solutions are on display ... in Vienna, Austria this week.   ...
Breaking Medicine Technology:Aethlon Medical to Present at the 27th Annual ROTH Conference 2Lilly and IU School of Medicine Partner on Rotation Program for Medical Students 2Lilly and IU School of Medicine Partner on Rotation Program for Medical Students 3Varian Medical Systems to Showcase New X-Ray Imaging Components at the European Congress of Radiology (ECR) Annual Meeting 2Varian Medical Systems to Showcase New X-Ray Imaging Components at the European Congress of Radiology (ECR) Annual Meeting 3
... American Medical Systems® (AMS) (NASDAQ: AMMD), a ... and female pelvic health, today announced it has received ... Welfare (MHLW) to market and distribute its GreenLight HPS® ... Hyperplasia (BPH), or enlarged prostate, in Japan. ...
... 2011 Misonix, Inc. (NASDAQ: MSON ), ... innovative, therapeutic, ultrasonic products worldwide for wound debridement, cosmetic ... applications, announced today that it will present at the ... 2011 at the Le Parker Meridien Hotel in New ...
Cached Medicine Technology:American Medical Systems' GreenLight HPS® Approved for Use in Japan 2Misonix to Present at the MDB Capital Bright Lights Conference on May 11, 2011 2
(Date:3/4/2015)... is no stranger to drug addiction. The bustling city has ... from the potential threat of Kratom. In a report by ... Kratom is a “drug of concern.” Although Kratom is legally ... Southeast Asia acts as a stimulant in low doses, yet ... similar to heroin withdrawal, and includes tremors, irritation, anxiety, and ...
(Date:3/4/2015)... SIGVARIS proved innovative when ... first compression therapy collection designed exclusively for men. ... USA is proud to announce the launch of three ... Constructed from a unique, extremely fine synthetic fiber, MIDTOWN ... socks and thigh-highs offer a tailored look that is ...
(Date:3/4/2015)... According to a new report published ... the U.S. suffer from gastroesophageal reflux disease (GERD), more ... to control acid production, but these can have side ... the problem and lead to other uncomfortable digestive conditions. ... the lower esophageal sphincter does not function properly. Anti-reflux ...
(Date:3/4/2015)... 04, 2015 In a small ceremony with ... on their new facility in New Port Richey on February ... new facility will allow the Florida drug detox facility ... drug abuse epidemic through treatment and education. “Due to our ... in the United States, we made the decision that expanding ...
(Date:3/4/2015)... 04, 2015 Jeannie Mai, TV personality, fashion ... graces the cover of the print publication. Mai embraces the ... organic when shopping for clothes and personal care products. In ... about her commitment to an organic diet. She mentions, “Having ... only in gymnastics, but also now as I’m a full ...
Breaking Medicine News(10 mins):Health News:Columbus, OH Combats the Sale of Kratom as a Drug, Harbor Village Detox Stresses Caution 2Health News:Building on the Success of MIDTOWN MICROFIBER, SIGVARIS Expands Popular Compression Collection with Longer Foot Length Offerings 2Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 2Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 3Health News:Novus Medical Detox Hosts Ribbon Cutting Ceremony at Pasco County Facility 2Health News:Novus Medical Detox Hosts Ribbon Cutting Ceremony at Pasco County Facility 3
... MINNEAPOLIS / ST. PAUL Minn. (October 28, 2010) ... Medical Center researchers have discovered a correlation between increased ... and the debilitating, involuntary flashbacks triggered by post traumatic ... PTSD through concrete evidence of neural activity, its impact ...
... HealthDay Reporter , THURSDAY, Oct. 28 (HealthDay ... green tea might help protect women from breast cancer, ... conclusion. "We found no overall association between green ... Japanese women who have habitually drunk green tea," said ...
... , WEDNESDAY, Oct. 27 (HealthDay News) -- Children ... increased risk for obesity in adulthood, a new study ... the symptoms of ADHD -- such as inattention, hyperactivity ... obese, according to researchers from Duke University Medical Center, ...
... , WEDNESDAY, Oct. 27 (HealthDay News) The ... are associated with heightened activity on the right side ... research that included 80 people with PTSD (many of ... and 284 people without the condition, researchers used a ...
... , BOSTON--A new oral drug caused dramatic shrinkage of a ... by an abnormally activated protein, physician-scientists from Dana-Farber Cancer Institute ... England Journal of Medicine . A second patient who ... mutant protein, called ALK (named for the first disease in ...
... A comprehensive review of national opinion polls, including newly released ... for a Democratic congressional candidate in 2010 and those who ... district hold starkly different views of what they want the ... between Democratic and Republican leaders in Congress on this issue. ...
Cached Medicine News:Health News:U of M researchers identify possible key to treating, understanding post-traumatic stress disorder 2Health News:Study Finds Green Tea Offers No Protection From Breast Cancer 2Health News:Children with ADHD Symptoms at Higher Risk of Obesity 2Health News:PTSD Linked to 'Hyperactivity' in Right Brain 2Health News:'Smart drug' targets new mutation, dramatically shrinks aggressive sarcoma and lung cancer 2Health News:'Smart drug' targets new mutation, dramatically shrinks aggressive sarcoma and lung cancer 3Health News:Prospective voters and the new health care law 2
The new CR6-45NM non-mydriatic retinal camera is an ideal diagnostic tool for ophthalmologists, optometrists and other medical professionals, especially when it comes to detecting and monitoring diab...
FF 450plus IRu Fundus camera with Visupac / System 431. Digital results in all capture modes and unlimited Visupac software....
An ideal choice for film photography. The new TRC-50FXC provides 35mm color and Polaroid capability....
The most advanced retinal cameras for fluorescein, color and ICG angiography with full digital imaging capability....
Medicine Products: